A study to identify potential differences in patient selection and management between treatment eras, reflecting the CAR-T learning curve, as well as determinants of improved outcome
Latest Information Update: 16 Jan 2023
At a glance
- Drugs Axicabtagene ciloleucel (Primary) ; Tisagenlecleucel (Primary)
- Indications B-cell lymphoma
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 16 Jan 2023 New trial record
- 13 Dec 2022 Results presented at the 64th American Society of Hematology Annual Meeting and Exposition